Former UN Special Representative on Business and Human Rights
John Ruggie, now a
senior advisor to our CSR practice, recently authored an article in Corporate
Secretary magazine in which he observed that there has
been a "convergence of expectations" with regard to
business responsibilities in the area of human rights.
[h]uman rights due diligence requires companies to develop
effective policies and procedures to assess the actual and
potential human rights impacts associated with their activities and
business relationships, and to act upon the findings.
Professor Ruggie observes that the Guiding Principles are
"not just another set of voluntary standards vying for
attention in an increasingly crowded space" but rather
represent "authoritative UN standards around which the
articulated expectations of many public and private institutions
have already converged." (emphasis added)
Specifically, as noted in the article, the United
States Council for International Business, the International
Organization of Employers, and the International Chamber of
Commerce have all voiced support for the Principles. The guidance
set forth in the Principles has also been incorporated into:
The revised Organization for Economic Cooperation and
Development ("OECD") Guidelines for Multinational
The revised International Finance Corporation ("IFC")
Sustainability Policy and the corresponding Performance Standards;
The ISO 26000 social responsibility standard adopted by
the International Organization for Standardization
The formal endorsement, and rapid incorporation, of the Guiding
Principles marks 2011 as a transformative year in the field of
business and human rights. Looking ahead to 2012 and beyond,
companies should expect that stakeholder expectations with regard
to corporate impacts on human rights will increasingly be informed
by this new framework.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Foley Hoag will present a 60-minute webinar on Wednesday, January 25, 2017 at 12:30 pm EST offering guidance to in-house counsel on best practices for pharmaceutical and biologics companies in selecting, vetting, and seeking approval for medication product names. The focus will be primarily on the U.S. market, although foreign strategies may be addressed as well.
25 Jan 2017, Seminar, Massachusetts, United States
Please join us on Wednesday, January 25 at the Westin Waltham Hotel for our quarterly New England M&A Forum, which brings the latest in market trends and recent legal developments to the New England M&A professionals' community.
Sellers love them, buyers hate them, but auctions are a mainstay of the M&A landscape. Our panel of experts, led by Foley Hoag partner Bill Kolb, will discuss legal, business and strategic considerations in structuring and participating in auctions from both the buy-side and the sell-side.
On November 9, 2016 Andrew Liazos presented at the New York City Bar. He discussed innovative approaches used by public companies during the 2016 proxy season for disclosing executive compensation practices.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).